Freed Inc

Corporate Fuel Advisors is a boutique middle market investment bank located in New York, specializing in strategic advisory, mergers and acquisitions, capital raising, and leadership recruiting services. The firm provides unbiased advice and seamless execution to business owners, corporate stakeholders, private equity firms, and investors looking to optimize their operational and financial strategies. With a focus on various industries such as clean technology, healthcare, and consumer products, Corporate Fuel Advisors assists clients in realizing the full value of their businesses through tailored financial guidance. Their experienced team navigates complex challenges and fosters growth through strategic transactions and superior leadership solutions. Generated from the website

The FAR Fund, based in New York, NY, is led by Executive Director Shirlee Taylor, Ph.D. The organization provides reporting grants to support various projects and initiatives in the community. With a focus on fostering impactful journalism, The FAR Fund aims to empower individuals and organizations to create meaningful change through their work. Through their grants, they strive to amplify important stories and voices that may otherwise go unheard.Generated from the website

New Leaf Venture Partners' objectives with each investment are to back a strong, entrepreneurial management team, to provide appropriate financial resources, to help build a great company, and to create exceptional equity value. We are active investors and almost always serve as directors of our portfolio companies, who can draw upon perspectives and experiences of the entire NLV investment team and its network of successful scientists, clinicians, operating executives and entrepreneurs. We assist in building management teams, guiding corporate strategy, providing input to operating plans, and in making decisions about optimal paths for future financings and exits. As conditions evolve, NLV Partners team continually refines its differentiated strategy in healthcare investing. Both of NLV's latest funds, New Leaf Ventures I and New Leaf Ventures II, focus on taking leadership positions in: Biopharmaceuticals - NLV has an in-depth understanding of therapeutic targets and modalities, the drug R&D process, clinical trial design, regulatory requirements, and pharmaceutical commercial activities. NLV's extensive medical, clinical development, commercial and financial experience helps companies navigate the challenging path to regulatory approval and commercialization as stand-alone companies or through value-added strategic partnerships. NLV invests in companies at all stages in this sector, but looks at the level of risk, costs, and timelines to build real value in the underlying program (s) in determining if an investment fits our strategy. NLV has been particularly active in starting and investing in companies that been formed around the spin out of programs from larger pharmaceutical and biotech companies. Medical devices - NLV works closely with its network of entrepreneurs and scientific and medical founders to identify investment opportunities around promising technologies targeting areas of high unmet medical need and large commercial potential. The current strategy is to focus on later stage opportunities to provide growth capital or the last round to profitability in which regulatory and reimbursement risks are minimal. NLV will invest in early stage companies when there are large established global markets and an opportunity to prove safety and effectiveness in a focused, cost effective program. NLV's investment team brings critical operating experience and the ability to evaluate the biological, engineering, regulatory, reimbursement and market risks most relevant to starting, growing, developing and exiting young or more mature companies in the medical devices sector.